Jump to content
Advocate Health
Search
Open menu
Cart
Login
Create Account
Bookmark/Search this post
Facebook
X
LinkedIn
Forward
Home
Grand Rounds/Case Conferences
Resources
Help
About Us
Continuing Education (CE) Planning
MOC Part IV
Forms
Disclosure
Mitigation
Clinical Content Review
Speaker Authorization
Learning Groups
CE Pre Planning Form
Contact Us
You are here
Home
Sessions
Access denied. You must log in to view this page.
Access denied. You must log in to view this page.
Session
Date
Peds Hem/Onc Independent Study 2025: January: “I Don’t Get to Play With My Mum Anymore”: Experiences of Siblings Aged 8–12 of Children With Cancer: A Qualitative Study
01/01/2025 - 6:00am CST
to
01/31/2025 - 11:59pm CST
Peds Hem/Onc Independent Study 2025: February: Seroprevalence of Measles (Rubeola) Antibodies in Childhood Cancer Survivors
02/01/2025 - 6:00am CST
to
02/28/2025 - 11:59pm CST
Peds Hem/Onc Independent Study 2025: March: Allopurinol use During Pediatric ALL Maintenance Therapy Corrects Kkewed 6MP Metabolism, Improving Inadequate Myelosuppression and Reducing Gastrointestinal Toxicity
03/01/2025 - 6:00am CST
to
03/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025 April: Evaluation of a nausea assessment tool in the pediatric oncology population
04/01/2025 - 6:00am CDT
to
04/30/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025 May: Fertility Preservation in Pediatric Leukemia and Lymphoma: A Report from the Children’s Oncology Group
05/01/2025 - 6:00am CDT
to
05/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: June: Neuropsychological Performance and Its Predictors in the Early Treatment Phase of Non-CNS Pediatric Cancer
06/01/2025 - 6:00am CDT
to
06/30/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: July: Deferiprone Versus Deferoxamine For Transfusional Iron Overload in Sickle Cell Disease and Other Anemias: Pediatric Subgroup Analysis of the Randomized, Open-label FIRST Study
07/01/2025 - 12:00am CDT
to
07/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: August: Immunoglobulin repletion during blinatumomab therapy does not reduce the rate of secondary hypogammaglobulinemia and associated infectious risk
08/01/2025 - 12:00am CDT
to
08/31/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: September: Burnout in Pediatric Oncology: Team Building and Clay Therapy as a Strategy to Improve Emotional Climate and Group Dynamics in a Nursing Staff
09/01/2025 - 12:01am CDT
to
09/30/2025 - 11:59pm CDT
Peds Hem/Onc Independent Study 2025: October: Gaps in Parental Understanding of Sleep Disturbances During Maintenance Therapy for Pediatric Acute Lymphoblastic Leukemia
10/01/2025 - 6:00am CDT
to
10/31/2025 - 11:59pm CDT
Pages
1
2
next ›
last »
Search
Home
Grand Rounds/Case Conferences
Resources
Help
About Us
Continuing Education (CE) Planning
MOC Part IV
Forms
Disclosure
Mitigation
Clinical Content Review
Speaker Authorization
Learning Groups
CE Pre Planning Form
Contact Us